Direxion Nanotechnology ETF
TYNE
TYNE was delisted on the 17th of February, 2023.
3 hedge funds and large institutions have $1.08M invested in Direxion Nanotechnology ETF in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
3% less capital invested
Capital invested by funds: $1.12M → $1.08M (-$35K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$22.9K |
| 2 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$3.02K |
TYNE Hedge Fund Activity: Q3 2022 in Review
3 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Direxion Nanotechnology ETF (TYNE) for Q3 2022, worth a combined $1.08M — down 3.1% from $1.12M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TYNE and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Citigroup, cutting an estimated $22.9K.
- 3 institutional investors held Direxion Nanotechnology ETF (TYNE) as of Q3 2022, down from 5 in Q2 2022.
- Funds reported $1.08M of Direxion Nanotechnology ETF stock for Q3 2022, down 3.1% quarter-over-quarter.
- 0 funds opened new Direxion Nanotechnology ETF positions in Q3 2022 and 2 closed out, a net change of -2 holders.
- The largest Direxion Nanotechnology ETF seller in Q3 2022 was Citigroup, an estimated $22.9K sold.
Based on aggregated 13F filings for Q3 2022.